Reward program. Lipovich will use a five-year, $2.3 million grant from the National Cancer Institute on a project to indentify primate-specific, long non-coding ribonucleic acids within the framework of breast cancer. The goal is to discover the extent to which non-conserved RNA genes contribute to the development of cancer. He is the first researcher from WSU to win the award.
—The InvestMidwest Venture Capital Forum is accepting applications from entrepreneurs who want to present at its 16th annual event, which is April 1-2, 2015 in Kansas City, MO. Click here to apply.
—There are several local personnel changes to report:
Arboretum Ventures in Ann Arbor has hired Thomas Shebab as a principal. Prior to joining Arboretum, Shebab, a gastroenterologist, was chief of staff at St. Joseph Mercy and chair of medicine for Integrated Health Associates.
Delphinius Medical Technologies, based in Plymouth Township, has added Chris Sanders as its vice president of engineering. Prior to starting at Delphinius, he served as director of ultrasound research and development at the Toshiba Medical Research Institute.
Ann Arbor’s Rubicon Genomics has hired Karl Hecker as its vice president of product development. Before joining Rubicon, Hecker held product development roles at Invitrogen, PerkinElmer, and Transgenomic. Rubicon also announced this month that it has signed distribution agreements in Europe, North Africa, and Asia for its DNA library preparation products.
